Welcome to our dedicated page for Medigus Ltd. American Depositary Share news (Ticker: MDGS), a resource for investors and traders seeking the latest updates and insights on Medigus Ltd. American Depositary Share stock.
Medigus Ltd. (MDGS) pioneers minimally invasive endoscopic solutions for gastrointestinal disorders, with its flagship SRS system transforming GERD treatment. This dedicated news hub provides investors and medical professionals with timely updates on the company’s technological advancements, regulatory milestones, and strategic partnerships.
Access comprehensive coverage of Medigus’ developments including product launches, clinical trial results, financial performance, and OEM manufacturing initiatives. Our curated repository ensures stakeholders stay informed about innovations in endoscopic stapling systems, ultrasonic alignment technologies, and collaborative healthcare projects.
Key updates feature progress in endoluminal procedures, manufacturing expansions, and intellectual property achievements. Regular updates include earnings reports, executive leadership changes, and research breakthroughs that underscore Medigus’ position in medical device innovation.
Bookmark this page for direct access to official press releases and objective analysis of Medigus’ contributions to minimally invasive surgery. Check regularly for verified updates on the company’s progress in redefining endoscopic intervention standards and expanding global healthcare partnerships.
Medigus Ltd. (Nasdaq: MDGS), a technology company specializing in electric vehicle charging solutions, has announced that its subsidiary, Charging Robotics Ltd., secured second place at the 14th Innovation World Cup, competing against approximately 400 global companies. This achievement highlights the innovation behind its Robotic Wireless Charging System, which incorporates advanced AI and machine learning to enhance charging performance. The system aims to wirelessly charge electric vehicles and is currently nearing completion of its first generation. Additionally, Charging Robotics has partnered with Make My Day to collect EV consumption data, optimizing the charging process through AI-driven systems. The company is also developing navigation algorithms for the robots, enhancing efficiency and user experience.
Medigus Ltd. (Nasdaq: MDGS) announced a significant share exchange transaction through its subsidiary, Charging Robotics Ltd., acquiring a 60% stake in Fuel Doctor, Inc. (FDOC). This move positions Charging Robotics as a wholly owned subsidiary of FDOC, allowing Medigus the option to increase its stake to 71% upon achieving certain milestones. At closing, FDOC reported $1 million in cash. Charging Robotics is developing a unique wireless charging system designed for public parking lots, which aims to reduce infrastructure installation costs and increase utilization rates. The system operates at 12kW, standard for residential chargers, greatly enhancing charging efficiency. Medigus focuses on advanced medical solutions, digital commerce, and electric vehicle technologies.
Medigus Ltd. (Nasdaq: MDGS) has acquired a 19.9% stake in Metagramm Software Ltd., an AI-driven grammar assistant, for $250,000 in common shares. This acquisition positions Medigus in the growing market of language assistance tools, projected to exceed $750 million by 2026, driven by demand for software solutions like Grammarly. Metagramm boasts an advanced grammar engine utilizing proprietary AI and NLP technology, offering tools for writing enhancement, grammar checking, and multilingual support. Additionally, Medigus is extending a $250,000 loan to Metagramm, repayable from future profits and secured by shares from current shareholders. This strategic investment aims to leverage the growing need for effective communication tools.
Medigus Ltd. (Nasdaq: MDGS) announced strong financial results for its subsidiary Viewbix for the fiscal year and fourth quarter ended December 31, 2022. Revenues reached a record high of $96.6 million, a 114% increase year-over-year, with fourth-quarter revenues also setting a record at $30.5 million, up 43%. EBITDA grew to $5.5 million, a 123% increase, while operating income rose to $2.7 million. Net profit surged to $1.1 million for the year, and $1.1 million for the fourth quarter, demonstrating substantial growth in profitability.
Medigus Ltd. (Nasdaq: MDGS) has announced that its portfolio company, ScoutCam Inc. (OTCQB: SCTC), successfully completed a private placement of 3,294,117 units at $4.25 each. This placement, amounting to approximately $14 million in gross proceeds, aims to enhance working capital and advance ScoutCam's Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies vital for Industry 4.0. Major investors included Mori Arkin and Phoenix Insurance. The funds will provide ScoutCam the resources needed to strengthen its position in the AI predictive maintenance market, underlining investor confidence despite market volatility.
Medigus Ltd. (Nasdaq: MDGS) announced that its affiliate, Jeffs' Brands Ltd., has entered a non-binding letter of intent with SuperBuzz Inc. to collaborate on AI-driven marketing solutions for Amazon. This partnership aims to enhance ad targeting and sales for Jeffs' Brands' products. As part of the deal, Jeffs' Brands could invest up to $2 million in SuperBuzz within 90 days after the definitive agreement is signed. Jeffs' Brands CEO, Viki Hakmon, expressed enthusiasm for leveraging AI to improve marketing effectiveness. Medigus, based in Israel, is involved in medical technologies and digital commerce, including ownership in Jeffs' Brands.
Medigus Ltd. (Nasdaq: MDGS) announced that ScoutCam Inc. (owned 27% by Medigus) and Elbit Systems Ltd. have successfully completed a development phase of ScoutCam's real-time video monitoring (RTVM) system. This system replaces manual inspections for unmanned aerial vehicles (UAVs) and enhances visibility in hard-to-reach areas. The modular design of ScoutCam’s RTVM system integrates advanced sensors and AI algorithms for predictive maintenance, significantly improving operational safety and reducing costs. CEO Yehu Ofer highlighted the potential of this technology across various sectors. Medigus is focused on innovative partnerships in medical solutions and electric vehicle technology.
Medigus Ltd. (Nasdaq: MDGS) announced that its fully owned subsidiary, Charging Robotics Ltd., has been nominated to submit its solution for the 14th Innovation World Cup, focusing on IoT and DeepTech. The proposed solution features advanced AI and machine learning algorithms to enhance the efficiency of a Robotic Wireless Charging System for electric vehicles (EVs). The first-generation system is nearing completion, with future upgrades set to leverage data on EV usage and charging processes. This initiative includes collaboration with Make My Day for EV fleet management, improving both user experience and environmental impact.